Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to a recent analysis.

A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans ...

GE HealthCare Technologies Inc. GEHC recently announced the launch of the Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. This AI-powered software function ...

Background: There is a paucity of data investigating the relationship between histopathologic variables of oncologic importance and prostate volume, and we aimed to investigate this. Methods: 2,207 ...